325 related articles for article (PubMed ID: 31115705)
1. Role of TRPC6 in Progression of Diabetic Kidney Disease.
Staruschenko A; Spires D; Palygin O
Curr Hypertens Rep; 2019 May; 21(7):48. PubMed ID: 31115705
[TBL] [Abstract][Full Text] [Related]
2. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
3. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
4. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
5. Protective role of Trpc6 knockout in the progression of diabetic kidney disease.
Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767
[TBL] [Abstract][Full Text] [Related]
6. TRPC Channels in Proteinuric Kidney Diseases.
Hall G; Wang L; Spurney RF
Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
[TBL] [Abstract][Full Text] [Related]
7. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
[TBL] [Abstract][Full Text] [Related]
8. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
9. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
10. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement.
Wang Q; Tian X; Wang Y; Wang Y; Li J; Zhao T; Li P
J Diabetes Res; 2020; 2020():6897390. PubMed ID: 31998809
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
12. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.
Dryer SE; Reiser J
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F689-701. PubMed ID: 20685822
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
14. Protective Role of Tangshen Formula on the Progression of Renal Damage in
Wang Q; Tian X; Zhou W; Wang Y; Zhao H; Li J; Zhou X; Zhang H; Zhao T; Li P
J Diabetes Res; 2020; 2020():3634974. PubMed ID: 33015191
[TBL] [Abstract][Full Text] [Related]
15. Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.
Yao X; Guo H; Sun M; Meng S; Zhu B; Fang J; Huang J; Wang H; Xing L
J Diabetes Res; 2022; 2022():1329380. PubMed ID: 35480629
[TBL] [Abstract][Full Text] [Related]
16. Gq signaling causes glomerular injury by activating TRPC6.
Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
18. Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels.
Ilatovskaya DV; Levchenko V; Lowing A; Shuyskiy LS; Palygin O; Staruschenko A
Sci Rep; 2015 Dec; 5():17637. PubMed ID: 26656101
[TBL] [Abstract][Full Text] [Related]
19. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.
Ma R; Chaudhari S; Li W
Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558
[TBL] [Abstract][Full Text] [Related]
20. Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy.
Hagmann H; Khayyat NH; Matin M; Oezel C; Chen H; Schauss A; Schell C; Benzing T; Dryer S; Brinkkoetter PT
Cells; 2023 Jan; 12(2):. PubMed ID: 36672207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
